TUBERCULOSIS, MULTIDRUG-RESISTANT
Clinical trials for TUBERCULOSIS, MULTIDRUG-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new TUBERCULOSIS, MULTIDRUG-RESISTANT trials appear
Sign up with your email to follow new studies for TUBERCULOSIS, MULTIDRUG-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for kids: new drug combo tackles tough TB
Disease control Recruiting nowThis study tests a drug called bedaquiline, given together with other TB medicines, in children and teens (birth to under 18 years) who have multidrug-resistant tuberculosis (MDR-TB). The goal is to see how safe the drug is, how the body processes it, and whether it helps fight t…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
Breakthrough trial aims to shorten Drug-Resistant TB treatment by months
Disease control Recruiting nowThis study tests if a shorter, personalized treatment plan can work as well as the standard long treatment for a type of drug-resistant tuberculosis (TB). About 400 adults with this specific TB will be randomly assigned to different treatment lengths and combinations. The goal is…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 05:42 UTC
-
TB study seeks volunteers to unlock disease secrets
Knowledge-focused Recruiting nowThis study aims to learn more about tuberculosis (TB) by collecting blood and other samples from people with active or latent TB. Researchers want to better understand how the disease works and how it affects the body. Participants will provide samples and may receive treatment f…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC